Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM586495 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | D3R2023 | ||
Kd | 1.90±n/a nM | ||
Citation | D3R, DD Drug Design Data Resource Grand Challenge 3 Dataset: p38a D3R D3R Publication Date 2/6/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM586495 | |||
n/a | |||
Name | BDBM586495 | ||
Synonyms: | D3RKN_3 | ||
Type | Small Organic Molecule | ||
Emp. Form. | C25H23BrF2N2O4 | ||
Mol. Mass. | 533.362 | ||
SMILES | Cc1ccc(cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O)C(=O)N1CC[C@@H](O)C1 |wD:31.34,(1.13,6.82,;2.47,6.05,;3.8,6.82,;5.14,6.05,;5.14,4.51,;3.8,3.74,;2.47,4.51,;1.13,3.74,;1.13,2.2,;2.47,1.43,;-.2,1.43,;-1.53,2.2,;-2.87,1.43,;-4.2,2.2,;-5.53,1.43,;-6.87,2.2,;-8.2,1.43,;-8.2,-.11,;-9.53,-.88,;-6.87,-.88,;-5.53,-.11,;-4.2,-.88,;-1.53,3.74,;-2.87,4.51,;-.2,4.51,;-.2,6.05,;6.47,3.74,;7.8,4.51,;6.47,2.2,;5.22,1.29,;5.7,-.17,;7.24,-.17,;8.14,-1.42,;7.72,1.29,)| | ||
Structure |